← Dashboard
Aug 20, 2026 08:10 AM ET
Signal
Corporate
NOVOZYMES Q2 REVENUE UP 9.8% Y/Y; RAISES FY26 ORGANIC SALES GROWTH OUTLOOK, INAUGURAL €1B SHARE BUYBACK PLAN - SEEKINGALPHA
Q2 revenue up 9.8% Y/Y, raised FY26 outlook, and inaugural €1B buyback.
What changed
Why it matters
Q2 revenue up 9.8% Y/Y, raised FY26 outlook, and inaugural €1B buyback.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
SCOTT BESSENT SURPRISE BOND BUYBACK SPARKS A SILVER RALLY . IS IT TOO LATE TO BUY IN ? →